Riskpilot← Back to searchSign inGet full accessGenoscoper Laboratories Oy
OYActiveY-tunnus 2850663-6Pl 82Diagnostic imaging services and medical laboratory activities · NACE 8691Est. 2017— employees
Revenue 2024
EUR 1,9M
+17% vs 2023
EBITDA margin
28.4%
+13% vs 2023
Equity ratio
53.1%
Financial strength
Net profit 2024
EUR 510K
+6% vs 2023
| Revenue | EUR 1,9M | +17% |
| EBITDA | EUR 530K | +13% |
| Net profit | EUR 510K | +6% |
| Total assets | EUR 3,3M | +8% |
| Equity | EUR 1,8M | +41% |
| Employees | — | — |
Legal name
Genoscoper Laboratories Oy
Y-tunnus number
2850663-6
Legal form
Osakeyhtiö
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
15. elokuuta 2017
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on eläinten DNA-tutkimuspalvelut ja eläinten laboratorionäytteiden testaus- ja analysointipalvelut kuten myös tieteellinen konsultointi eläinten DNA-tutkimukseen ja -analysointiin liittyen, myös eläinten geenitestit ja DNA-diagnostiikkapalvelut. Lisäksi yhtiön toimialana on eläinten polveutumismäärityspalvelut ja konsultointi liittyen eläinlääkintäpalveluihin sekä eläinten DNA-tietoja sisältävä sähköinen tietokantaohjelma.
Address
Pl 82
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 312 | 1 339 | 1 575 | 1 593 | 1 870 |
| Staff expenses | −560 | −405 | −309 | −283 | −260 |
| EBITDA | 230 | 373 | 686 | 468 | 530 |
| Depreciation & amort. | −341 | −2 | — | −0 | −0 |
| EBIT | −111 | 371 | 686 | 468 | 530 |
| Net financials | −1 | −3 | −7 | 13 | −21 |
| Profit before tax | −111 | 369 | 679 | 480 | 510 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −111 | 369 | 679 | 480 | 510 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 333 | 723 | 1 595 | 3 072 | 3 318 |
| Equity | 156 | 524 | 1 204 | 1 253 | 1 763 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 178 | 199 | 391 | 1 819 | 1 555 |
| Total debt | 178 | 199 | 391 | 1 819 | 1 555 |
EBITDA margin
28.4%
This company
15.8%
Market median
+80% vs market
20202024
Equity ratio
53.1%
This company
38.2%
Market median
+39% vs market
20202024
Return on equity
28.9%
This company
18.4%
Market median
+57% vs market
20202024
Net profit margin
27.3%
This company
8.1%
Market median
+237% vs market
20202024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20202024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Deputy Member | Deputy Member | 2025 |
| Former (4) | ||
| Audit | 2023 – 2023 | |
HJ | Audit | 2020 – 2023 |
SS | Audit | 2017 – 2020 |
HM Deputy Member | Deputy Member | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairperson | 2024 | |
| Former (8) | ||
| Board of Directors | 2018 – 2019 | |
| Chairperson | 2019 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Chairperson | 2018 – 2019 | |
| Board of Directors | 2019 – 2020 | |
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2018 – 2022 | |
| Chairperson | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mars Finland Oy
Genoscoper Laboratories Oy Board members of Genoscoper Laboratories Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lilli Fanny Kristiina Johansson | Audit | 0 companies |
| Heikki Juhani Lassila | Audit | 0 companies |
| Sami Seppo Sakari Posti | Audit | 0 companies |
| Kimberly Ann Honeycutt | Deputy Member | 0 companies |
| Hanna Maria Pärssinen | Deputy Member | 0 companies |
| Christine Karen Fong | Board of Directors | 0 companies |
| Giambattista Martano | Chairperson | 0 companies |
| Aymeric Marie Joseph du Peloux | Board of Directors | 0 companies |
| Kyoung Yo Yoo | Chairperson | 0 companies |
| Timothy Hirsch | Board of Directors | 0 companies |
| Cynthia Cole | Chairperson | 0 companies |
| Katja Annika Jauni | Board of Directors | 0 companies |
| Randall Wayne Lowell | Board of Directors | 0 companies |
| Jonas Christian Donner | Board of Directors | 0 companies |
| Zachary Mark Smith | Chairperson | 0 companies |